Innovating Works

H2020

Cerrada
HORIZON-EIC-2022-TRANSITIONOPEN-01
EIC Transition Open 2022
Expected Impact:At the end of the EIC Transition project, it should be ready for the next stage, which can be to apply for EIC Accelerator (if you are a SME, including start-ups or spin-offs), to seek other investors or sources of funding, to enter licensing or collaboration agreements with third parties, or other routes to market deployment. In case the project is not led by an SME or commercial partner, the formation and spin out of a new company can be included as part of the activities. It will be expected to describe the intended pathway and route to market in the proposal, and to specify milestones and KPIs during the implementation of your project to assess progress towards the market.
Sólo fondo perdido 100%
Europeo
Mostrando 101 al 120 de 328 resultados
EmbeDL: Faster and More Energy Efficient Machine Learning for Embedded Systems EMBEDL AB tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 EmbeDL is a Software Development Kit installed on premises to optimise complex DL models on embedded hardware systems. It empowers product m...
2023-03-19 - 2025-03-31 | Financiado
FLUAR: FLUAR - A novel solution for fluorescence-guided surgery based on augmented reality ARSPECTRA S.A.R.L. tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Fluorescence-guided surgery (FGS) uses near-infrared (NIR) sensors to detect and display fluorescent biomarkers indicating the exact locatio...
2023-03-17 - 2025-03-31 | Financiado
3DPRINTOPTIXMARKET: 3D Printed Micro-Optics to the Market PRINTOPTIX GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 In the project 3DPrintoptixMarket, we are going to take 3D printed micro-optics to the market. The technology had been developed in the fram...
2023-03-16 - 2026-05-31 | Financiado
TOPFIBRO: Targeting OGG1 in Idiopathic Pulmonary Fibrosis OXCIA AB tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 Idiopathic Pulmonary Fibrosis (IPF) is a progressive lung disease with no curative therapies. Approved therapies for IPF have a high rate of...
2023-03-16 - 2026-04-30 | Financiado
Gate2Brain: Gate2Brain. Medicines beyond barriers. GATE2BRAIN SL tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 In 2019, 30 million people worldwide were diagnosed with some form of CNS disorder and most of them lack effective treatment. This is largel...
2023-03-16 - 2025-03-31 | Financiado
inPhocal: Development of an enhanced laser beam technology based on a new optical system for industrial laser... INPHOCAL BV tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Although inkjet marking systems are widely used for marking the products, factors such as high running costs and low quality of marks are pr...
2023-03-16 - 2024-12-31 | Financiado
Reverion: Reversibly operating fuels cells for clean energy and long-term storage REVERION GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 The main innovation of Reverion is a patented (2 patents already granted, 4 submitted and other 6 planned), disruptive new system architectu...
2023-03-16 - 2025-01-31 | Financiado
NANO-ENGINE: A revolutionary cell programming platform based on the targeted nano-delivery of a transposon gene e... UNIVERSITEIT UTRECHT tramitó un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 Aim: The NANO-ENGINE project aims to develop a first-in-class, DNA-based, non-viral, targeted in vivo cell programming technology that can b...
2023-03-15 - 2026-03-31 | Financiado
CARxALL: Next generation, off-the-shelf, non fratricide-directed, CAR immunotherapy for relapse/refractory T-... ONECHAIN IMMUNOTHERAPEUTICS SL tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 R/R T-ALL remains a major clinical challenge. Despite improved survival rates thanks to intensive chemotherapy regimens, event-free (EFS) an...
2023-03-13 - 2026-03-31 | Financiado
SOIL2POWER: SOIL microbial fuel cells TO 2 POWER precise irrigation systems. ARKYNE TECHNOLOGIES tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 Smart agriculture is determined to play a major role to foster water and energy conservation solutions, and innovation technologies should b...
2023-03-13 - 2026-02-28 | Financiado
REPRESSIT: REPRESSIT: A novel class of clinical immune checkpoint inhibitors STICHTING NEDERLANDSE WETENSCHAPPELIJK ONDERZOEK INSTITUTEN tramitó un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 In the tumor microenvironment, continuous or tonic stimulation of T cells induces checkpoint signaling through inhibitory immune receptors (...
2023-03-13 - 2028-04-30 | Financiado
PeptiCHIP: Pre-clinical validation and demonstration of PeptiCHIP: an immunopurification microfluidic device an... VALO THERAPEUTICS OY tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 Clinical translation of cancer immunotherapies remains very challenging since 60-80% of patients fail to respond. The challenge stands in id...
2023-03-13 - 2025-03-31 | Financiado
MagSense: Hyperpolarized NMR made simple NVISION IMAGING TECHNOLOGIES GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 Nuclear magnetic resonance (NMR) is one of the most powerful analytical techniques currently available, with applications ranging from synth...
2023-03-13 - 2025-03-31 | Financiado
BioScale: Biosensor Activated Biomanufacturing Scale-up ENDURO GENETICS APS tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Industrial Biotechnology is one of the Key Enabling Technologies (KETs) identified by Europe. Harnessing the power of microbes for biomanufa...
2023-03-08 - 2025-03-31 | Financiado
FUNAMBULIST: FUnctional Nucleic Acids as Versatile SMart BUilding BLocks in Non ConventIonal SolvenTs UNIVERSIDAD DEL PAIS VASCO/EUSKAL HERRIKO UNIBERTSITATEA tramitó un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 Almost half of the production costs in the rapidly growing chiral chemicals market is spent on the downstream processing costs due to challe...
2023-03-08 - 2026-04-30 | Financiado
TRACKR: An AI powered turn-key solution for MRI based interventional cardiology NANO4IMAGING GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Nano4Imaging (N4I) is a med-tech company specialized in MR based interventional radiology. We have previously successfully commercialized Em...
2023-03-08 - 2025-03-31 | Financiado
IonKraftCoating: Plasma technology as enabler for sustainable plastic packaging IONKRAFT GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Only 6% of the plastic packaging produced yearly is recycled. A reason for this is that many products demand a barrier effect of their packa...
2023-03-06 - 2025-03-31 | Financiado
SAFEWater-SDCW: A Disruptively Novel Approach to Clean and Safe Water Supply to Off-Grid Communities – SAFEWater-SDC... SOLAR DEW CLEAN WATER BV tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 SolarDew has developed a disruptive, point of use water purification technology. It may look like a solar panel but instead of electricity,...
2023-03-05 - 2025-09-30 | Financiado
edge air: On the edge AI-driven Autonomous Inspection Robots ENERGY ROBOTICS GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Energy Robotics proposes an end-to-end robot agnostic AI-driven software platform that enables a diverse fleet of mobile robots to autonomou...
2023-03-02 - 2025-03-31 | Financiado
SafeWax: Sustainable Bioinspired Wax Coating for Multi-Functional Crop Protection TECHNION ISRAEL INSTITUTE OF TECHNOLOGY tramitó un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 According to the FAO, plant diseases cost the global economy around 210€ billion per year, and fungal pathogens destroy at least a third of...
2023-03-01 - 2027-02-28 | Financiado